Fujifilm says COVID-19 drug research may drag on into July
FILE PHOTO: Tablets of Avigan (generic name : Favipiravir), a drug approved as an anti-influenza drug in Japan and developed by drug maker Toyama Chemical Co, a subsidiary of Fujifilm…
AstraZeneca scores twin drug approvals alongside vaccine progress
(Reuters) – Britain’s AstraZeneca has clinched expanded regulatory backing for two medications, including one for blockbuster cancer treatment Lynparza, in a development pipeline that now includes a possible coronavirus vaccine.…
Michigan, California move to reopen factories as U.S. jobless ranks grow
DETROIT/SACRAMENTO, Calif. (Reuters) – Michigan and California, two U.S. manufacturing powerhouses, acted on Thursday to allow factories to reopen from coronavirus lockdowns over the next few days, as millions more…
Roche gets FDA emergency use approval for COVID-19 antibody test
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland January 30, 2020. REUTERS/Arnd Wiegmann/File Photo (Reuters) – Roche Holding AG (ROG.S) received emergency…
U.S. FDA approves first rapid coronavirus test with 45 minutes detection time
FILE PHOTO: A computer image created by Nexu Science Communication together with Trinity College in Dublin, shows a model structurally representative of a betacoronavirus which is the type of virus…
Germany tries to stop U.S. poaching German firm seeking coronavirus vaccine
BERLIN (Reuters) – Berlin is trying to stop Washington from persuading a German company seeking a coronavirus vaccine to move its research to the United States, prompting German politicians to…
Germany tries to stop U.S. from luring away firm seeking coronavirus vaccine
BERLIN (Reuters) – Berlin is trying to stop Washington from persuading a German company seeking a coronavirus vaccine to move its research to the United States, prompting German politicians to…
Pharma firms not making enough progress against superbugs: report
LONDON (Reuters) – Drug companies are not making progress against the spread of antibiotic resistance at a scale and speed great enough to tackle the global health threat posed by…
Biogen scraps development of therapy for rare brain disease
(Reuters) – Biogen Inc said on Friday it would discontinue the development of its experimental therapy for a rare brain disease after the treatment failed a mid-stage trial, the latest…
Sarepta shares surge after surprise approval of Duchenne Muscular Dystrophy drug
(Reuters) – Shares of Sarepta Therapeutics Inc (SRPT.O) soared 36% on Friday after U.S. regulators shocked Wall Street by approving the company’s treatment for a muscle-wasting disorder less than four…